Literature DB >> 2347733

RTOG quality assurance guidelines for clinical trials using hyperthermia.

M W Dewhirst1, T L Phillips, T V Samulski, P Stauffer, P Shrivastava, B Paliwal, T Pajak, M Gillim, M Sapozink, R Myerson.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2347733     DOI： 10.1016/0360-3016(90)90466-w

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  12 in total

1.  A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer.

Authors:  Zeljko Vujaskovic; Dong W Kim; Ellen Jones; Lan Lan; Linda McCall; Mark W Dewhirst; Oana Craciunescu; Paul Stauffer; Vlayka Liotcheva; Allison Betof; Kimberly Blackwell
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

Review 2.  Hyperthermia: How Can It Be Used?

Authors:  Zhaleh Behrouzkia; Zahra Joveini; Behnaz Keshavarzi; Nazila Eyvazzadeh; Reza Zohdi Aghdam
Journal:  Oman Med J       Date:  2016-03

3.  Accuracy of real time noninvasive temperature measurements using magnetic resonance thermal imaging in patients treated for high grade extremity soft tissue sarcomas.

Authors:  Oana I Craciunescu; Paul R Stauffer; Brian J Soher; Cory R Wyatt; Omar Arabe; Paolo Maccarini; Shiva K Das; Kung-Shan Cheng; Terence Z Wong; Ellen L Jones; Mark W Dewhirst; Zeljko Vujaskovic; James R MacFall
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

Review 4.  Present and future technology for simultaneous superficial thermoradiotherapy of breast cancer.

Authors:  Eduardo G Moros; Jose Peñagaricano; Petr Novàk; William L Straube; Robert J Myerson
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

5.  Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy.

Authors:  Donald E Thrall; Susan M LaRue; Daohai Yu; Thaddeus Samulski; Linda Sanders; Beth Case; Gary Rosner; Chieko Azuma; Jeannie Poulson; Amy F Pruitt; Wilma Stanley; Marlene L Hauck; Laurel Williams; Paul Hess; Mark W Dewhirst
Journal:  Clin Cancer Res       Date:  2005-07-15       Impact factor: 12.531

6.  'Patchwork' fields in thermoradiotherapy for extensive chest wall recurrences of breast carcinoma.

Authors:  K Engin; L Tupchong; F M Waterman; L Komarnicky; C M Mansfield; D B Leeper
Journal:  Breast Cancer Res Treat       Date:  1993-09       Impact factor: 4.872

7.  Optimization of Single Voxel MR Spectroscopy Sequence Parameters and Data Analysis Methods for Thermometry in Deep Hyperthermia Treatments.

Authors:  J Hartmann; J Gellermann; T Brandt; M Schmidt; S Pyatykh; J Hesser; O Ott; R Fietkau; C Bert
Journal:  Technol Cancer Res Treat       Date:  2016-07-14

8.  Thermal boost combined with interstitial brachytherapy in breast conserving therapy - Assessment of early toxicity.

Authors:  Adam Chicheł; Janusz Skowronek; Marek Kanikowski
Journal:  Rep Pract Oncol Radiother       Date:  2011-04-08

9.  Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer.

Authors:  Timothy M Zagar; Zeljko Vujaskovic; Silvia Formenti; Hope Rugo; Franco Muggia; Brigid O'Connor; Robert Myerson; Paul Stauffer; I-Chow Hsu; Chris Diederich; William Straube; Mary-Keara Boss; Alina Boico; Oana Craciunescu; Paolo Maccarini; David Needham; Nicholas Borys; Kimberly L Blackwell; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2014-08       Impact factor: 3.914

Review 10.  Quality assurance guidelines for superficial hyperthermia clinical trials : II. Technical requirements for heating devices.

Authors:  Hana Dobšíček Trefná; Johannes Crezee; Manfred Schmidt; Dietmar Marder; Ulf Lamprecht; Michael Ehmann; Jacek Nadobny; Josefin Hartmann; Nicolleta Lomax; Sultan Abdel-Rahman; Sergio Curto; Akke Bakker; Mark D Hurwitz; Chris J Diederich; Paul R Stauffer; Gerard C Van Rhoon
Journal:  Strahlenther Onkol       Date:  2017-03-01       Impact factor: 3.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.